CRBP Latest Press Releases

-- March 9, 2026 --

Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update Globe Newswire 7:30 AM

-- February 12, 2026 --

Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference Globe Newswire 8:00 AM

-- January 5, 2026 --

Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 7:30 AM

-- December 11, 2025 --

Corbus Pharmaceuticals Reports Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss Globe Newswire 7:00 AM

-- December 10, 2025 --

Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025 Globe Newswire 4:01 PM

-- November 12, 2025 --

Corbus Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides a Corporate Update Globe Newswire 8:00 AM

-- October 31, 2025 --

Corbus Pharmaceuticals Announces Pricing of Public Offering Globe Newswire 2:40 AM

-- October 30, 2025 --

Corbus Pharmaceuticals Announces Proposed Public Offering Globe Newswire 4:31 PM

-- October 18, 2025 --

Corbus Pharmaceuticals Presents CRB-701 Robust Clinical Responses in HNSCC and Cervical Cancers at ESMO25 Globe Newswire 3:00 AM

-- October 14, 2025 --

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025 Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software